Martine A. Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS Corp (UTHR), sold 9,500 shares at $560.05 ($5.5M) on 2026-10-01, disclosed to the SEC on 2026-10-02.
Scheduled sale ($5.5M) by Chairperson & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $560.05 | 120 | $67K | 1.2% |
| 2 | $561.68 | 80 | $45K | 0.8% |
| 3 | $563.31 | 160 | $90K | 1.6% |
| 4 | $567.90 | 94 | $53K | 1.0% |
| 5 | $569.65 | 306 | $174K | 3.2% |
| 6 | $570.55 | 534 |
| $305K |
| 5.6% |
| 7 | $571.52 | 320 | $183K | 3.3% |
| 8 | $572.86 | 560 | $321K | 5.9% |
| 9 | $573.62 | 280 | $161K | 2.9% |
| 10 | $574.94 | 830 | $477K | 8.7% |
| 11 | $575.90 | 1,346 | $775K | 14.2% |
| 12 | $576.91 | 774 | $447K | 8.2% |
| 13 | $577.93 | 930 | $537K | 9.8% |
| 14 | $579.02 | 320 | $185K | 3.4% |
| 15 | $580.20 | 864 | $501K | 9.2% |
| 16 | $581.21 | 702 | $408K | 7.5% |
| 17 | $582.24 | 520 | $303K | 5.5% |
| 18 | $583.28 | 400 | $233K | 4.3% |
| 19 | $584.66 | 360 | $210K | 3.8% |
| Total | $576.47 avg | 9,500 | $5.5M | 100% |
| Filing → |
| UTHR | SELL | 2026-10-07 | $5.1M | — | Filing → |
| UTHR | SELL | 2026-10-06 | $5.1M | — | Filing → |
| UTHR | SELL | 2026-10-05 | $5.2M | — | Filing → |